FDA Updates Hydrochlorothiazide Label for Nonmelanoma Skin Cancer FDA Updates Hydrochlorothiazide Label for Nonmelanoma Skin Cancer
Hydrochlorothiazide is associated with an increased risk of nonmelanoma skin cancer, according to updates to the medication ' s label.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 24, 2020 Category: Cancer & Oncology Tags: Cardiology News Source Type: news
Innovative smartphone-camera adaptation images melanoma and non-melanoma
(SPIE--International Society for Optics and Photonics) An article published in the Journal of Biomedical Optics (JBO), " Point-of-care, multispectral, smartphone-based dermascopes for dermal lesion screening and erythema monitoring, " shows that standard smartphone technology can be adapted to image skin lesions, providing a low-cost, accessible medical diagnostic tool for skin cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 23, 2020 Category: International Medicine & Public Health Source Type: news
U.S. FDA Approves IMBRUVICA ® (ibrutinib) Plus Rituximab for the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)
HORSHAM, Pa., April 21, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of IMBRUVICA® (ibrutinib) in combination with rituximab for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who are new to therapy. The approval is based on positive results from the landmark Phase 3 E1912 study that was designed and conducted by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and sponsored by the National Cancer Institute, part of the National Institutes of Health. Today’s milestone mar...
Source: Johnson and Johnson - April 22, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Blood Mercury Levels Linked to Nonmelanoma Skin Cancer
Increased blood total mercury levels, methylmercury levels linked to increased odds of NMSC (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 5, 2020 Category: Cancer & Oncology Tags: Dermatology, Family Medicine, Internal Medicine, Oncology, Pathology, Journal, Source Type: news
Blood Mercury Levels Linked to Nonmelanoma Skin Cancer
WEDNESDAY, Feb. 5, 2020 -- Blood mercury (Hg) levels are associated with nonmelanoma skin cancer (NMSC), according to a study published online Feb. 5 in the British Journal of Dermatology.
J. Rhee, from the Warren Alpert Medical School of Brown... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 5, 2020 Category: Pharmaceuticals Source Type: news
UArizona receives $6.9m grant to study prevention of non-melanoma skin cancer
(University of Arizona Health Sciences) Skin cancer is the most common malignancy worldwide, and one in three new cancers diagnosed is a form of skin cancer. In response, a team of researchers at the University of Arizona Cancer Center is developing new strategies to prevent and reduce the risk of squamous cell carcinoma, the second most-common form of non-melanoma skin cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 5, 2020 Category: Cancer & Oncology Source Type: news
Do elevated mercury levels in the blood increase skin cancer risk?
(Wiley) Higher levels of mercury in the blood were linked with a higher prevalence of non-melanoma skin cancer, the most common human malignancy, in a study published in the British Journal of Dermatology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 5, 2020 Category: Cancer & Oncology Source Type: news
2012 to 2014 Saw 41,185 U.S. Patients With Skin Malignancy
MONDAY, Dec. 9, 2019 -- From 2012 to 2014, 41,185 patients with a diagnosis of skin malignancy of the head and neck region were identified, mostly with a diagnosis of nonmelanoma skin cancer (NMSC), according to a study recently published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 9, 2019 Category: Pharmaceuticals Source Type: news
RSNA: Brachytherapy Treats Skin Cancer in Elderly Patients
Brachytherapy alternative to Mohs surgery in early - stage nonmelanoma skin cancers of head, neck (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 5, 2019 Category: Cancer & Oncology Tags: Dermatology, Oncology, Radiology, Geriatrics, Conference News, Source Type: news
RSNA: Brachytherapy Treats Skin Cancer in Elderly Patients
THURSDAY, Dec. 5, 2019 -- Excellent local control and cosmetic outcomes are observed in elderly patients receiving high dose-rate brachytherapy (HDRBT) for early-stage nonmelanoma skin cancer of the head and neck region, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 5, 2019 Category: Pharmaceuticals Source Type: news
Mesothelioma Death from 9/11 Signals Start of Things to Come
Malignant mesothelioma has become the latest deadly cancer linked directly to the rescue, recovery and cleanup efforts following the 9/11 terrorist attack on New York City in 2001.
The long-running threat has come to fruition.
Eighteen years after Manhattan was engulfed in the asbestos-laced, toxic cloud of dust — caused primarily by the World Trade Center destruction — the first death from pleural mesothelioma attributed to 9/11 has been recorded.
Nick Ursta, 52, from the southwestern part of Pennsylvania, died after a year-long battle with the rare cancer.
Ursta, a construction worker and fireman by trade, was part ...
Source: Asbestos and Mesothelioma News - November 14, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news
Sensus' revenues slip in Q3
Lower sales of its robotic intraoperative radiation therapy system adversely...Read more on AuntMinnie.comRelated Reading:
Sensus scores Premier contract for brachytherapy
Sensus inks R&D pact with UPenn
Sensus touts research for nonmelanoma skin cancer
FDA clears Sensus Healthcare's IORT system
Sensus names new VP of clinical development (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 7, 2019 Category: Radiology Source Type: news
Outcomes Across Nonmelanoma Skin Cancer Treatments Similar
Brachytherapy and Mohs micrographic surgery show better cosmetic results (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 23, 2019 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pharmacy, Surgery, Journal, Source Type: news
Outcomes Across Nonmelanoma Skin Cancer Treatments Similar
WEDNESDAY, Oct. 23, 2019 -- Outcomes for nonmelanoma skin cancers are similar at one year, regardless of treatment type, although cosmetic results vary, according to a review published in the Oct. 15 issue of Cancer.
Charles T. Lee, Pharm.D., M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 23, 2019 Category: Pharmaceuticals Source Type: news
Why Are Non-Melanoma Skin Cancers Untreated in the Elderly
Why are geriatric patients less likely to get treated for their non-melanoma skin cancers? Researchers investigate and report. (Source: CancerNetwork)
Source: CancerNetwork - October 20, 2019 Category: Cancer & Oncology Authors: Leanne Marcello, MS Source Type: news
